(-0.31%) 5 020.05 points
(0.26%) 37 913 points
(-0.39%) 15 597 points
(-3.28%) $79.24
(-2.46%) $1.942
(0.51%) $2 314.70
(0.42%) $26.77
(1.09%) $958.55
(-0.01%) $0.937
(-0.05%) $11.09
(0.10%) $0.801
(-0.48%) $93.00
Quarter results tomorrow
(bmo 2024-05-02)
Expected move: +/- 12.03%
0.00% $ 0.661
Live Chart Being Loaded With Signals
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe...
Stats | |
---|---|
Volumen de hoy | 321 668 |
Volumen promedio | 139 878 |
Capitalización de mercado | 821 028 |
EPS | $0 ( 2024-04-01 ) |
Próxima fecha de ganancias | ( $0 ) 2024-05-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.0120 (1.96%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-22 | Burns Thomas M. | Buy | 2 400 | Non-Employee Stock Option |
2023-06-22 | Burns Thomas M. | Buy | 0 | |
2023-06-22 | Varian John | Buy | 1 200 | Non-Employee Stock Option |
2023-06-22 | Panem Sandra Phd | Buy | 1 200 | Non-Employee Stock Option |
2023-06-22 | Kelley John P | Buy | 1 200 | Non-Employee Stock Option |
INSIDER POWER |
---|
99.33 |
Last 96 transactions |
Buy: 1 532 806 | Sell: 94 790 |
Volumen Correlación
Acorda Therapeutics Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
HCTI | 0.95 |
TVTX | 0.945 |
ALBO | 0.939 |
MNST | 0.934 |
CMPI | 0.93 |
GNLN | 0.929 |
APLT | 0.929 |
MORF | 0.924 |
SBET | 0.922 |
UFO | 0.922 |
10 Correlaciones Más Negativas | |
---|---|
NTGR | -0.928 |
PI | -0.928 |
ATRS | -0.919 |
PPBT | -0.916 |
HONE | -0.912 |
CPSI | -0.912 |
BRAC | -0.908 |
KDNY | -0.907 |
MSAC | -0.903 |
LGTO | -0.901 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Acorda Therapeutics Inc Correlación - Moneda/Commodity
Acorda Therapeutics Inc Finanzas
Annual | 2023 |
Ingresos: | $117.63M |
Beneficio Bruto: | $71.59M (60.86 %) |
EPS: | $-203.59 |
FY | 2023 |
Ingresos: | $117.63M |
Beneficio Bruto: | $71.59M (60.86 %) |
EPS: | $-203.59 |
FY | 2022 |
Ingresos: | $118.57M |
Beneficio Bruto: | $88.23M (74.42 %) |
EPS: | $-66.90 |
FY | 2021 |
Ingresos: | $129.07M |
Beneficio Bruto: | $88.28M (68.40 %) |
EPS: | $-12.86 |
Financial Reports:
No articles found.
Acorda Therapeutics Inc
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS product for the treatment of acute migrain; rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico